Clinical trial

Project 2 Airway Potential Hydrogen (pH) in Asthma

NCT03617718

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2018-11-01Date precision: day

Registry last updated2025-08-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cystic Fibrosisunresolved

Asthmaunresolved

Severe Persistent Asthmaunresolved

Healthyunresolved

Interventions

Glycine BufferDRUG

Sponsors & collaborators

Case Western Reserve Universitylead sponsor

National Institutes of Health (NIH)collaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

University Hospitals Cleveland Medical Centercollaborator

Mapped research locations

ClevelandOhio, United States1 IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03617718 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.